Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barter

Showing results (381-390 of 390) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 390 results.
Journal of Lipid Research|August 3, 2005
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemiaYi Yu, Diego F Wyszynski, Dawn M Waterworth, et al.
Diabetes|December 3, 2016
Erratum. Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism. Diabetes 2016;65:3610-3620Blake J Cochran, Liming Hou, Anil Paul Chirackal Manavalan, et al.
Diabetes|October 6, 2016
Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle MetabolismBlake J Cochran, Liming Hou, Anil Paul Chirackal Manavalan, et al.
JHEP Reports : Innovation in Hepatology|January 24, 2022
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevanceKatherine Johnson, Peter J Leary, Olivier Govaere, et al.
JAMA|November 15, 2020
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical TrialStephen J Nicholls, A Michael Lincoff, Michelle Garcia, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.
The New England Journal of Medicine|May 18, 2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular DiseaseA Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
Atherosclerosis. Supplements|September 16, 2011
Familial hypercholesterolaemia: a model of care for AustralasiaGerald F Watts, David R Sullivan, Nicola Poplawski, et al.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Pageof 39

Showing results (381-390 of 390) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 390 results.
Journal of Lipid Research|August 3, 2005
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemiaYi Yu, Diego F Wyszynski, Dawn M Waterworth, et al.
Diabetes|December 3, 2016
Erratum. Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism. Diabetes 2016;65:3610-3620Blake J Cochran, Liming Hou, Anil Paul Chirackal Manavalan, et al.
Diabetes|October 6, 2016
Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle MetabolismBlake J Cochran, Liming Hou, Anil Paul Chirackal Manavalan, et al.
JHEP Reports : Innovation in Hepatology|January 24, 2022
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevanceKatherine Johnson, Peter J Leary, Olivier Govaere, et al.
JAMA|November 15, 2020
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical TrialStephen J Nicholls, A Michael Lincoff, Michelle Garcia, et al.
The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.
The New England Journal of Medicine|May 18, 2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular DiseaseA Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
Atherosclerosis. Supplements|September 16, 2011
Familial hypercholesterolaemia: a model of care for AustralasiaGerald F Watts, David R Sullivan, Nicola Poplawski, et al.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Pageof 39